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We report here three unusual cases of otomastoiditis due to Francisella tularensis, 
complicated by cervical abscesses and persistent hearing loss, plus facial paralysis for 
one patient. Intriguingly, the three patients had practiced canyoneering independently in 
the same French river, between 2009 and 2014, several days before clinical symptoms 
onset. The results point out that fresh water exposure may be a potential contamination 
route for tularemia. Besides, due to the frequent complications and sequelae, we believe 
that F. tularensis should be considered as a possible etiology in case of otitis media, 
failure of the conventional antibiotic treatment, and suspicious exposure of the bacteria.
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INtRoDUCtIoN
We here report the first series of culture and/or PCR – documented Francisella tularensis otomas-
toiditis. Intriguingly, the three patients had all independently practiced canyoneering between 2008 
and 2014 in the same French river several days before clinical signs onset.
patient 1
The observation has already been published as a single case report by Gürkov et  al. (1), but the 
epidemiologic link with the present series was uncovered by Guerpillon and Gürkov when retrospec-
tively questioning the patient. Briefly, in summer 2008, a 27-year-old female with no comorbidity 
presented with acute otitis media and retropharyngeal swelling after 5 weeks of empirical treatment 
by subsequent amoxicillin, cefuroxim, and ceftriaxone. Computed Tomography scan (CT-scan) 
revealed a retropharyngeal abscess and mastoiditis.
patient 2
The following summer (2009), a 39-year-old female with no known comorbidity presented to an 
Ear Nose and Throat (ENT) emergency unit for vestibular disorders, conductive deafness, and fever. 
She reported being under clavulanic acid–amoxicilin for the past 2 weeks due to a sore throat with 
adenopathies. CT-scan confirmed the unilateral right otitis media and mastoiditis.
taBLe 1 | Characteristics of patients in a series of Francisella tularensis subsp. holarctica otomastoiditis.
patient 1 (1) patient 2 patient 3
Date July 2008 July 2009 May 2014
Gender Female Female Male
Age (years old) 27 39 43
Incubation (days) <7 10 3–7
Clinical presentation Pharyngitis Pharyngitis Tonsillitis (right-side)
Purulent left otitis media Purulent right otitis media Purulent right otitis media
Retropharyngeal swelling Submandibular adenopathy Subdigastric adenopathy
Complications Cervical phlegmonous 
inflammation
Conductive deafness 
(15–30 dB)
Retropharyngeal abscess
Mastoiditis
Conductive deafness (40 dB)
Mastoiditis
Vestibular disorders
Facial peripheral paralysis
Mixt deafness (40 dB in low pitch and 
80 dB in high pitch)
Mastoiditis
CRP upon hospital admission 36 mg/L 90 mg/L 155 mg/L
Empirical treatment active for  
Francisella tularensis
None Ofloxacin (8 days) Amikacin (5 days)
Elapsed time between clinical signs 
onset and diagnosis (days)
44 25 28
Microbiological diagnostic techniques 16S PCR  
Serology
Culture Culture
Francisella tularensis-specific PCR 16S PCR
Francisella tularensis-specific PCR
Bacterial etiology Francisella tularensis subsp. 
holarctica
Francisella tularensis subsp. holarctica Francisella tularensis subsp. 
holarctica
Treatment (from diagnosis) Day 1–5: doxycyclin Day 0–4: gentamicin
Day 0–25: ciprofloxacin
Day 0–45: ciprofloxacin + doxycycline
Day 45–78: no treatmentDay 1–23: ciprofloxacin
Day 11–23: gentamicin Day 89: transtympanic tube Day 78–108: doxycyclin
Paracentesis
Lesions needle aspiration
Surgical drainage
Outcome Conductive deafness (8-month 
follow-up)
Conductive deafness (10 dB) minor vestibular 
disorders (10-month follow-up)
Asymptomatic (2-month follow-up)
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patient 3
The third case occurred in summer 2014 and involved a 43-year-
old canyoneering instructor with no notable medical history. 
After 5 days suffering from right otalgia with accompanying hear-
ing loss and asthenia, the patient received an empirical course of 
oral amoxicillin followed by oral cefpodoxim and ibuprofen from 
his general practitioner. No clinical improvement was observed. 
Thirteen days after the onset of clinical signs, the patient began 
suffering from right facial paralysis and thus consulted to an ENT 
department. Upon clinical examination, homolateral sensorineu-
ral deafness and right-side tonsilitis with a subdigastric adenopa-
thy were noted. Peripheral grade 6 facial paralysis was confirmed 
(2). Otoscopy of the right side showed inflammatory stenotic 
external auditory canal. A paracentesis was performed, leading to 
a purulent discharge. Biological examination revealed an inflam-
matory syndrome (Table 1). CT-scan (Figure 1) confirmed the 
acute otitis media of the right ear, with blockage of the middle ear 
and the tympanic cavity, partial blockage of the mastoid cells, and 
the internal portion of the external auditory canal, as well as a lat-
eral pharyngeal adenopathy on the right side (16 mm × 19 mm) 
and tonsillitis. Upon hospital admission, piperacillin–tazobactam 
(12 g/day) with a daily injection of amikacin (15 mg/kg) and topi-
cal ofloxacin (200  mg/day) treatment was initiated. Prednisone 
(1 mg/kg/day, 6 days) was added to treat the facial paralysis.
BaCKGRoUND
Francisella tularensis is a bacterial agent of pleomorphic 
anthropozoonoses, such as ulceroglandular or oropharyngeal 
syndromes and pneumonia, depending on the route of inocula-
tion. Acute otitis tularemia is excessively rare; only two cases have 
been described so far (1, 3). Contaminated water is known as the 
route of oropharyngeal infection when ingested (4–7). However, 
to our knowledge, direct skin contact when bathing has never 
been pointed out as the source of infection.
DIsCUssIoN
patient 1
16S rDNA polymerase chain reaction (16S PCR) testing of an 
adenopathy aspirated fluid revealed the presence of F. tularensis 
subsp holarctica DNA. The positive serology performed con-
comitantly corroborated the results, leading to a final diagnosis 
44 days after the onset of the symptoms. Adapted antibiotic treat-
ment (Table 1) combined with paracentesis and repeated needle 
aspirations of the suppurative lesions remained inefficient. Only 
open surgical drainage allowed to cure the infection. Finally, the 
patient, a music teacher, suffered from a lasting conductive deaf-
ness of 15–30 dB (1).
FIGURe 1 | Mastoid Ct scan of patient 3. (a) High-resolution axial section focus of the right temporal bone. Acute otitis media with tympanomastoid 
homogenous opacity inflammatory filling of the whole tympanic cavity (*) and mastoid cells (*). (B) Swelling related to the right tonsillitis (*).
March 2016 | Volume 3 | Article 93
Guerpillon et al. Keep an Ear Out for Francisella tularensis
Frontiers in Medicine | www.frontiersin.org
The patient reported canyoneering practice in the river Le 
Grenant during her journey to France, 7 days before the clinical 
onset.
patient 2
Bacteriological analysis of an otorrhea sample yielded monomi-
crobial culture of F. tularensis after 15 days incubation (i.e., 25 days 
after the onset of symptoms). The expertise of the French National 
Reference Center for Francisella allowed the identification of the 
subspecies holarctica by specific PCR. A first 1-week course of 
oral ofloxacin (200  mg twice a day) leading to partial clinical 
improvement only, a combined treatment with oral ciprofloxacin 
for 25 days and gentamicin for 5 days was initiated (Table 1). Ten 
months after the end of treatment, conductive deafness (10 dB) 
and minor vestibular disorders still remained.
Canyoneering in the river Le Grenant 10 days before the onset 
of the symptoms was the only exposure factor revealed by the 
medical history.
patient 3
The bacteriological analysis of the paracentesis pus sample 
yielded a monomicrobial culture of Gram negative bacilli after 
3 days incubation, identified as F. tularensis by 16S PCR (4), and 
confirmed as F. tularensis subsp. holartica by the French National 
Reference Center using specific PCR. The facial paralysis, angina, 
and asthenia regressed after 5  days of amikacin/piperacillin–
tazobactam treatment; the subdigastric adenopathy diminished 
while persistent. Antibiotic treatment was then adapted with oral 
ciprofloxacin and doxycycline plus topical ofloxacin for 45 days. 
Regarding the hearing loss, repeated audiometric reports revealed 
improvement of conductive audition despite no restitution ad 
integrum. After 45 days, the patient could not stand anymore the 
lack of physical activity imposed by fluoroquinolone administra-
tion and ceased his treatment. Due to the diagnosis delay and 
the initial loco-regional extension, he finally complied with the 
medical team suggestion for another 30 days of doxycycline.
The follow-up MRI (Figure 2) and PET scan after 3 months 
showed satisfactory evolution with a minimal persistence of 
gadolinium enhancement in the right mastoid, and moderate 
hyper fixation of the right mastoid cells, respectively, with no 
other associated bone or tissue anomaly. The patient felt perfectly 
healthy. Noticeably, as a canyoneering instructor, the patient 
reported sessions in Le Grenant river (France) 3–7 days before 
the first clinical signs.
CoNCLUDING ReMaRKs
We report here the first series of three cases of F. tularensis 
otomastoiditis, which is an extremely rare localization, and may 
be related to an aquatic inoculation. Noticeably, the clinical pres-
entation included severe deafness for all patients, possibly with 
retropharyngeal abscess and/or facial paralysis. Besides, the three 
cases noticeably occurred independently between 2008 and 2014 
after a common exposure to the same French river (Le Grenant) 
3–10 days before the clinical symptoms onset, which is consistent 
with the mean incubation period (3–5 days) (8). Given the very 
low incidence of tularemia in France, it is thus likely that the river 
was the common source of infection to the three cases.
Transmission occurs by ingestion, inhalation, or contact 
between contaminated liquids and human mucus. Moreover, F. 
tularensis is hosted in rodents and lagomorphs, and can be intro-
duced into watercourses from animal carcasses (9, 10). Strikingly, 
a tannery was found to be closely located upstream from the 
canyoneering spot on the river border. Following the report of the 
case 2 (while not knowing the link of case 1 with the same river), 
the health authorities initiated a field survey and discovered that 
wastewater was discharged to the river. Bacteriological analyses of 
sewage and river water did not detect the presence of Francisella 
DNA, although only small volumes of water samples could be 
analyzed leading to a possible lack of sensitivity.
Given the complications observed due to the delay of diag-
nosis and the ineffectiveness of beta-lactams, we insist on this 
FIGURe 2 | post treatment imaging. (a) Gadolinium-enhanced axial T1 weighted fat-suppressed MRI. Minimal persistence of gadolinium enhancement in the 
right mastoid. (B) PET CT fused image. Good aeration and minimal persistence of 18 FDG uptake in the right mastoid. No other associated bone or tissue anomaly.
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possible etiology in case of otitis media associated with fresh-water 
 exposure and persisting after conventional antibiotic courses.
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